Vascular-targeted Photodynamic Therapy in Unilateral Low-risk Prostate Cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical Prostatectomy

Risk Prostate Cancer ◽

Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States

The Journal of Urology ◽

10.1016/j.juro.2016.05.113 ◽

2016 ◽

Vol 196 (4) ◽

pp. 1096-1104 ◽

Cited By ~ 31

Author(s):

Samir S. Taneja ◽

James Bennett ◽

Jonathan Coleman ◽

Robert Grubb ◽

Gerald Andriole ◽

...

Keyword(s):

Prostate Cancer ◽

United States ◽

Photodynamic Therapy ◽

Phase I ◽

The United States ◽

Multicenter Trial ◽

Low Risk ◽

Risk Prostate Cancer ◽

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer

The Lancet Oncology ◽

10.1016/s1470-2045(17)30170-5 ◽

2017 ◽

Vol 18 (4) ◽

pp. e187 ◽

Cited By ~ 2

Author(s):

Weigang Yan ◽

Yi Zhou ◽

Zhien Zhou ◽

Zhigang Ji ◽

Hanzhong Li

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Active Surveillance ◽

Low Risk ◽

Risk Prostate Cancer ◽

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer – Authors' reply

The Lancet Oncology ◽

10.1016/s1470-2045(17)30163-8 ◽

2017 ◽

Vol 18 (4) ◽

pp. e188 ◽

Cited By ~ 3

Author(s):

Abdel-Rahmène Azzouzi ◽

Mark Emberton

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Active Surveillance ◽

Low Risk ◽

Risk Prostate Cancer ◽

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(16)30661-1 ◽

2017 ◽

Vol 18 (2) ◽

pp. 181-191 ◽

Cited By ~ 131

Author(s):

Abdel-Rahmène Azzouzi ◽

Sébastien Vincendeau ◽

Eric Barret ◽

Antony Cicco ◽

François Kleinclauss ◽

...

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Risk Prostate Cancer ◽

Open Label Phase ◽

Randomised Controlled ◽

468 Cancer volume is an independent predictor for biochemical progression and clinical failure in high-risk prostate cancer patients following radical prostatectomy : A single centre experience

European Urology Supplements ◽

10.1016/s1569-9056(13)60951-3 ◽

2013 ◽

Vol 12 (1) ◽

pp. e468-e469

Author(s):

L. Hakim ◽

M. Spahn ◽

P. Gontero ◽

S. Van Bruwaene ◽

A. Briganti ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Independent Predictor ◽

Clinical Failure ◽

Single Centre ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Biochemical Progression

Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients after radical prostatectomy – a single centre experience

European Urology Supplements ◽

10.1016/s1569-9056(17)31351-9 ◽

2017 ◽

Vol 16 (5) ◽

pp. e2204-e2205

Author(s):

D. Milonas ◽

A. Opolskis ◽

L. Jarusevicius ◽

M. Jievaltas

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Salvage Radiotherapy ◽

Single Centre ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Vascular Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Midterm Oncologic Outcomes

The Journal of Urology ◽

10.1016/j.juro.2017.03.119 ◽

2017 ◽

Vol 198 (2) ◽

pp. 335-344 ◽

Cited By ~ 10

Author(s):

Souhil Lebdai ◽

Pierre Bigot ◽

Pierre-Adrien Leroux ◽

Louis-Paul Berthelot ◽

Pierre Maulaz ◽

...

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Cancer Treatment ◽

Low Risk ◽

Oncologic Outcomes ◽

Prostate Cancer Treatment ◽

Risk Prostate Cancer ◽

A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland

Irish Journal of Medical Science (1971 -) ◽

10.1007/s11845-013-1024-9 ◽

2013 ◽

Vol 183 (3) ◽

pp. 377-382 ◽

Cited By ~ 10

Author(s):

J. C. Forde ◽

P. J. Daly ◽

S. White ◽

M. Morrin ◽

G. P. Smyth ◽

...

Keyword(s):

Prostate Cancer ◽

Active Surveillance ◽

Management Strategy ◽

Low Risk ◽

Single Centre ◽

Risk Prostate Cancer ◽

Low Risk Prostate Cancer

Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment

Asian Journal of Andrology ◽

10.4103/aja.aja_138_19 ◽

2020 ◽

Vol 22 (5) ◽

pp. 454

Author(s):

Samuel Chelly ◽

Pierre Maulaz ◽

Pierre Bigot ◽

AbdelRahmene Azzouzi ◽

Souhil Lebdai

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Cancer Treatment ◽

Erectile Function ◽

Low Risk ◽

Prostate Cancer Treatment ◽

Risk Prostate Cancer ◽

Sexual function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment

European Urology Supplements ◽

10.1016/s1569-9056(19)30461-0 ◽

2019 ◽

Vol 18 (1) ◽

pp. e623-e625

Author(s):

S. Chelly ◽

P. Maulaz ◽

P. Bigot ◽

A.R. Azzouzi ◽

S. Lebdai

Keyword(s):

Prostate Cancer ◽

Photodynamic Therapy ◽

Sexual Function ◽

Cancer Treatment ◽

Low Risk ◽

Prostate Cancer Treatment ◽

Risk Prostate Cancer ◽